Redburn starts Domino’s with Sell on heavy GLP-1 exposure

As previously reported, Redburn Atlantic initiated coverage of Domino’s Pizza (DPZ) with a Sell rating and $340 price target Domino’s faces the heaviest pressure from GLP-1 weight loss drug adoption, with high exposure to dinner occasions and lower-income consumers, the analyst tells investors in a research note. The firm says the company’s organic traffic remains weak, with carryout far outpacing delivery. With system sales growth challenged and consensus expectations still elevated, there is downside risk for Domino’s, contends Redburn.